CoChat
Cited by 26

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Inhibitory and stimulatory micropeptides preferentially bind to different conformations of the cardiac calcium pump

Cleary, Sean R., Fang, Xuan, Cho, Ellen E., Pribadi, Marsha P., Seflova, Jaroslava, Beach, Jordan R., Kekenes-Huskey, Peter M., Robia, Seth L. · 2022 · Journal of Biological Chemistry

Published version of a preprint

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jbc.2022.102060

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 55

  1. Currie, 1999, Enhanced phosphorylation of phospholamban and downregulation of sarco/endoplasmic reticulum Ca ATPase type 2 (SERCA 2) in cardiac sarcoplasmic reticulum from rabbits with heart failure, Cardiovasc. Res., 41, 135, 10.1016/S0008-6363(98)00241-7 · DOI
  2. Hasenfuss, 1994, Relation between myocardial function and expression of sarcoplasmic reticulum Ca2+-ATPase in failing and nonfailing human myocardium, Circ. Res., 75, 434, 10.1161/01.RES.75.3.434 · DOI · Paper page
  3. Hayward, 2015, The current and future landscape of SERCA gene therapy for heart failure: a clinical perspective, Hum. Gene Ther., 26, 293, 10.1089/hum.2015.018 · DOI
  4. Kranias, 2012, Modulation of cardiac contractility by the phopholamban/SERCA2a regulatome, Circ. Res., 110, 1646, 10.1161/CIRCRESAHA.111.259754 · DOI · Paper page
  5. Cantilina, 1993, Comparative studies of cardiac and skeletal sarcoplasmic reticulum ATPases. Effect of a phospholamban antibody on enzyme activation by Ca2+, J. Biol. Chem., 268, 17018, 10.1016/S0021-9258(19)85295-X · DOI · Paper page
  6. Tada, 1975, Phosphorylation of a 22,000-dalton component of the cardiac sarcoplasmic reticulum by adenosine 3':5'-monophosphate-dependent protein kinase, J. Biol. Chem., 250, 2640, 10.1016/S0021-9258(19)41650-5 · DOI · Paper page
  7. Galani-Kranias, 1980, Phosphorylation of a 100 000 dalton component and its relationship to calcium transport in sarcoplasmic reticulum from rabbit skeletal muscle, Biochim. Biophys. Acta, 628, 438, 10.1016/0304-4165(80)90393-1 · doi:10.1016/0304-4165(80)90393-1
  8. Asahi, 2000, Physical interactions between phospholamban and sarco(endo)plasmic reticulum Ca2+-ATPases are dissociated by elevated Ca2+, but not by phospholamban phosphorylation, vanadate, or thapsigargin, and are enhanced by ATP, J. Biol. Chem., 275, 15034, 10.1074/jbc.275.20.15034 · DOI
  9. James, 1989, Nature and site of phospholamban regulation of the Ca2+ pump of sarcoplasmic reticulum, Nature, 342, 90, 10.1038/342090a0 · DOI · Paper page
  10. Toyoshima, 2003, Modeling of the inhibitory interaction of phospholamban with the Ca2+ ATPase, Proc. Natl. Acad. Sci. U. S. A., 100, 467, 10.1073/pnas.0237326100 · DOI · Paper page
  11. Chen, 2010, Ca2+ binding to site I of the cardiac Ca2+ pump is sufficient to dissociate phospholamban, J. Biol. Chem., 285, 3253, 10.1074/jbc.M109.080820 · doi:10.1074/jbc.m109.080820
  12. Jones, 2002, Close proximity between residue 30 of phospholamban and cysteine 318 of the cardiac Ca2+ pump revealed by intermolecular thiol cross-linking, J. Biol. Chem., 277, 28319, 10.1074/jbc.M204085200 · DOI
  13. Karim, 2006, Phosphorylation-dependent conformational switch in spin-labeled phospholamban bound to SERCA, J. Mol. Biol., 358, 1032, 10.1016/j.jmb.2006.02.051 · DOI · Paper page
  14. Bidwell, 2011, Phospholamban binds with differential affinity to calcium pump conformers, J. Biol. Chem., 286, 35044, 10.1074/jbc.M111.266759 · DOI · Paper page
  15. Alford, 2020, Protein docking and steered molecular dynamics suggest alternative phospholamban-binding sites on the SERCA calcium transporter, J. Biol. Chem., 295, 11262, 10.1074/jbc.RA120.012948 · DOI
  16. Fisher, 2021, Dwarf open reading frame (DWORF) is a direct activator of the sarcoplasmic reticulum calcium pump SERCA, Elife, 10, e65545, 10.7554/eLife.65545 · DOI
  17. Kimura, 1997, Phospholamban inhibitory function is activated by depolymerization, J. Biol. Chem., 272, 15061, 10.1074/jbc.272.24.15061 · DOI · Paper page
  18. Hou, 2008, Phosphomimetic mutations increase phospholamban oligomerization and alter the structure of its regulatory complex, J. Biol. Chem., 283, 28996, 10.1074/jbc.M804782200 · DOI
  19. Cornea, 1997, Mutation and phosphorylation change the oligomeric structure of phospholamban in lipid bilayers, Biochemistry, 36, 2960, 10.1021/bi961955q · DOI · Paper page
  20. Song, 2011, Phosphomimetic mutations enhance oligomerization of phospholemman and modulate its interaction with the Na/K-ATPase, J. Biol. Chem., 286, 9120, 10.1074/jbc.M110.198036 · DOI
  21. Robia, 2007, Forster transfer recovery reveals that phospholamban exchanges slowly from pentamers but rapidly from the SERCA regulatory complex, Circ. Res., 101, 1123, 10.1161/CIRCRESAHA.107.159947 · DOI
  22. Koch, 2021, Molecular noise filtering in the beta-adrenergic signaling network by phospholamban pentamers, Cell Rep, 36, 109448, 10.1016/j.celrep.2021.109448 · DOI
  23. Li, 2021, The transmembrane peptide DWORF activates SERCA2a via dual mechanisms, J. Biol. Chem., 296, 100412, 10.1016/j.jbc.2021.100412 · DOI · Paper page
  24. Makarewich, 2018, The DWORF micropeptide enhances contractility and prevents heart failure in a mouse model of dilated cardiomyopathy, Elife, 7, 10.7554/eLife.38319 · DOI · Paper page
  25. Singh, 2019, Newly discovered micropeptide regulators of SERCA form oligomers but bind to the pump as monomers, J. Mol. Biol., 431, 4429, 10.1016/j.jmb.2019.07.037 · DOI · Paper page
  26. Nelson, 2016, A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle, Science, 351, 271, 10.1126/science.aad4076 · DOI · Paper page
  27. Makarewich, 2020, Gene therapy with the DWORF micropeptide attenuates cardiomyopathy in mice, Circ. Res., 127, 1340, 10.1161/CIRCRESAHA.120.317156 · DOI · Paper page
  28. Mbikou, 2020, Cardiovascular effects of DWORF (dwarf open reading frame) peptide in normal and ischaemia/reperfused isolated rat hearts, Peptides, 124, 170192, 10.1016/j.peptides.2019.170192 · DOI
  29. Albers, 1967, Biochemical aspects of active transport, Annu. Rev. Biochem., 36, 727, 10.1146/annurev.bi.36.070167.003455 · DOI · Paper page
  30. Autry, 2012, Nucleotide activation of the Ca-ATPase, J. Biol. Chem., 287, 39070, 10.1074/jbc.M112.404434 · DOI
  31. Clausen, 2012, Distinct roles of the C-terminal 11th transmembrane helix and luminal extension in the partial reactions determining the high Ca2+ affinity of sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2b (SERCA2b), J. Biol. Chem., 287, 39460, 10.1074/jbc.M112.397331 · doi:10.1074/jbc.m112.397331
  32. Dode, 2003, Dissection of the functional differences between sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) 1 and 2 isoforms and characterization of Darier disease (SERCA2) mutants by steady-state and transient kinetic analyses, J. Biol. Chem., 278, 47877, 10.1074/jbc.M306784200 · DOI
  33. Hughes, 1996, An investigation of the mechanism of inhibition of the Ca(2+)-ATPase by phospholamban, Biochem. J., 318, 973, 10.1042/bj3180973 · DOI
  34. Mintz, 1995, The modulation of Ca2+ binding to sarcoplasmic reticulum ATPase by ATP analogues is pH-dependent, J. Biol. Chem., 270, 27160, 10.1074/jbc.270.45.27160 · doi:10.1074/jbc.270.45.27160
  35. Bovo, 2016, R-CEPIA1er as a new tool to directly measure sarcoplasmic reticulum [Ca] in ventricular myocytes, Am. J. Physiol. Heart Circ. Physiol., 311, H268, 10.1152/ajpheart.00175.2016 · DOI
  36. Stewart, 2018, Computational modeling of amylin-induced calcium dysregulation in rat ventricular cardiomyocytes, Cell Calcium, 71, 65, 10.1016/j.ceca.2017.11.006 · DOI
  37. Mueller, 2004, Direct detection of phospholamban and sarcoplasmic reticulum Ca-ATPase interaction in membranes using fluorescence resonance energy transfer, Biochemistry, 43, 8754, 10.1021/bi049732k · DOI · Paper page
  38. Fukuzawa, 2021, When is an obscurin variant pathogenic? The impact of Arg4344Gln and Arg4444Trp variants on protein-protein interactions and protein stability, Hum. Mol. Genet., 30, 1131, 10.1093/hmg/ddab010 · DOI
  39. Bluhm, 2000, Phospholamban: a major determinant of the cardiac force-frequency relationship, Am. J. Physiol. Heart Circ. Physiol., 278, H249, 10.1152/ajpheart.2000.278.1.H249 · DOI
  40. Meyer, 1999, Phospholamban-to-SERCA2 ratio controls the force-frequency relationship, Am. J. Physiol., 276, H779
  41. Wu, 2012, CaMKII effects on inotropic but not lusitropic force frequency responses require phospholamban, J. Mol. Cell. Cardiol., 53, 429, 10.1016/j.yjmcc.2012.06.019 · DOI
  42. Mulieri, 1992, Altered myocardial force-frequency relation in human heart failure, Circulation, 85, 1743, 10.1161/01.CIR.85.5.1743 · DOI · Paper page
  43. Autry, 2011, Oligomeric interactions of sarcolipin and the Ca-ATPase, J. Biol. Chem., 286, 31697, 10.1074/jbc.M111.246843 · DOI
  44. Hou, 2012, 2-Color calcium pump reveals closure of the cytoplasmic headpiece with calcium binding, PLoS One, 7, 10.1371/journal.pone.0040369 · DOI
  45. Gruber, 2014, Discovery of enzyme modulators via high-throughput time-resolved FRET in living cells, J. Biomol. Screen., 19, 215, 10.1177/1087057113510740 · DOI · Paper page
  46. Raguimova, 2018, Redistribution of SERCA calcium pump conformers during intracellular calcium signaling, J. Biol. Chem., 293, 10843, 10.1074/jbc.RA118.002472 · DOI
  47. Bovo, 2019, Novel approach for quantification of endoplasmic reticulum Ca(2+) transport, Am. J. Physiol. Heart Circ. Physiol., 316, H1323, 10.1152/ajpheart.00031.2019 · DOI
  48. Blackwell, 2016, Cardiac calcium ATPase Dimerization measured by cross-linking and fluorescence energy transfer, Biophys. J., 111, 1192, 10.1016/j.bpj.2016.08.005 · DOI
  49. Ferrington, 2002, Comparable levels of Ca-ATPase inhibition by phospholamban in slow-twitch skeletal and cardiac sarcoplasmic reticulum, Biochemistry, 41, 13289, 10.1021/bi026407t · DOI · Paper page
  50. Seflova, 2022, Fluorescence lifetime imaging microscopy reveals sodium pump dimers in live cells, J Biol Chem, 298, 101865, 10.1016/j.jbc.2022.101865 · DOI
  51. Schoenmakers, 1992, Chelator: an improved method for computing metal ion concentrations in physiological solutions, Biotechniques, 12, 870
  52. Lambert, 2019, FPbase: a community-editable fluorescent protein database, Nat. Methods, 16, 277, 10.1038/s41592-019-0352-8 · DOI · Paper page
  53. Sun, 2019, Thermodynamics of cation binding to the sarcoendoplasmic reticulum calcium ATPase pump and impacts on enzyme function, J. Chem. Theory Comput., 15, 2692, 10.1021/acs.jctc.8b01312 · DOI
  54. Lamberth, 2000, NMR solution structure of phospholamban, Helv. Chim. Acta., 83, 2141, 10.1002/1522-2675(20000906)83:9<2141::AID-HLCA2141>3.0.CO;2-W · DOI · Paper page
  55. Fernandez-de Gortari, 2018, Structural basis for relief of phospholamban-mediated inhibition of the sarcoplasmic reticulum Ca(2+)-ATPase at saturating Ca(2+) conditions, J. Biol. Chem., 293, 12405, 10.1074/jbc.RA118.003752 · DOI

Cited by

Metadata

Authors
Cleary, S. R., Fang, X., Cho, E. E., Pribadi, M. P., Seflova, J., Beach, J. R., Kekenes-Huskey, P. M., & Robia, S. L.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2022-07
Volume
298
Issue
7
Pages
102060
ISSN
0021-9258
Cited by
26
References
5
Language
en
Licence
Funders
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (R01HL092321, R01HL143816)
  • National Institute of General Medical Sciences (K22HL133150, R35GM124977, MIRA R35GM138183)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.